The global market for Inflammatory Bowel Disease (IBD) Treatment was valued at US$ 1866 million in the year 2024 and is projected to reach a revised size of US$ 3154 million by 2031, growing at a CAGR of 7.9% during the forecast period.

Inflammatory Bowel Disease (IBD) Treatment Market

Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding.

The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.

This report aims to provide a comprehensive presentation of the global market for Inflammatory Bowel Disease (IBD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inflammatory Bowel Disease (IBD) Treatment.

The Inflammatory Bowel Disease (IBD) Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Inflammatory Bowel Disease (IBD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Inflammatory Bowel Disease (IBD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Inflammatory Bowel Disease (IBD) Treatment Market Report

Report Metric	Details
Report Name	Inflammatory Bowel Disease (IBD) Treatment Market
Accounted market size in year	US$ 1866 million
Forecasted market size in 2031	US$ 3154 million
CAGR	7.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	TNF Inhibitors Aminosalicyclates Immunomodulators Corticosteroids
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Pfizer, Takeda, Janssen Biotech, Allergan, Bausch Health, Takeda Pharmaceutical, Novartis, Biogen
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inflammatory Bowel Disease (IBD) Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Inflammatory Bowel Disease (IBD) Treatment Market growing?

Ans: The Inflammatory Bowel Disease (IBD) Treatment Market witnessing a CAGR of 7.9% during the forecast period 2025-2031.

What is the Inflammatory Bowel Disease (IBD) Treatment Market size in 2031?

Ans: The Inflammatory Bowel Disease (IBD) Treatment Market size in 2031 will be US$ 3154 million.

Who are the main players in the Inflammatory Bowel Disease (IBD) Treatment Market report?

Ans: The main players in the Inflammatory Bowel Disease (IBD) Treatment Market are AbbVie, Pfizer, Takeda, Janssen Biotech, Allergan, Bausch Health, Takeda Pharmaceutical, Novartis, Biogen

What are the Application segmentation covered in the Inflammatory Bowel Disease (IBD) Treatment Market report?

Ans: The Applications covered in the Inflammatory Bowel Disease (IBD) Treatment Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Inflammatory Bowel Disease (IBD) Treatment Market report?

Ans: The Types covered in the Inflammatory Bowel Disease (IBD) Treatment Market report are TNF Inhibitors, Aminosalicyclates, Immunomodulators, Corticosteroids

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 TNF Inhibitors

1.2.3 Aminosalicyclates

1.2.4 Immunomodulators

1.2.5 Corticosteroids

1.3 Market by Application

1.3.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Perspective (2020-2031)

2.2 Global Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Region

2.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Region (2020-2025)

2.2.3 Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Region (2026-2031)

2.3 Inflammatory Bowel Disease (IBD) Treatment Market Dynamics

2.3.1 Inflammatory Bowel Disease (IBD) Treatment Industry Trends

2.3.2 Inflammatory Bowel Disease (IBD) Treatment Market Drivers

2.3.3 Inflammatory Bowel Disease (IBD) Treatment Market Challenges

2.3.4 Inflammatory Bowel Disease (IBD) Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue

3.1.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue (2020-2025)

3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue

3.4 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio

3.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2024

3.5 Global Key Players of Inflammatory Bowel Disease (IBD) Treatment Head office and Area Served

3.6 Global Key Players of Inflammatory Bowel Disease (IBD) Treatment, Product and Application

3.7 Global Key Players of Inflammatory Bowel Disease (IBD) Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Type

4.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Type (2020-2025)

4.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2026-2031)

5 Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Application

5.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Application (2020-2025)

5.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size (2020-2031)

6.2 North America Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025)

6.4 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2020-2031)

7.2 Europe Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025)

7.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size (2020-2031)

8.2 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size (2020-2031)

9.2 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025)

9.4 Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size (2020-2031)

10.2 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Introduction

11.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.1.5 AbbVie Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Introduction

11.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Takeda

11.3.1 Takeda Company Details

11.3.2 Takeda Business Overview

11.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Introduction

11.3.4 Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.3.5 Takeda Recent Development

11.4 Janssen Biotech

11.4.1 Janssen Biotech Company Details

11.4.2 Janssen Biotech Business Overview

11.4.3 Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Introduction

11.4.4 Janssen Biotech Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.4.5 Janssen Biotech Recent Development

11.5 Allergan

11.5.1 Allergan Company Details

11.5.2 Allergan Business Overview

11.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Introduction

11.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.5.5 Allergan Recent Development

11.6 Bausch Health

11.6.1 Bausch Health Company Details

11.6.2 Bausch Health Business Overview

11.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Introduction

11.6.4 Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.6.5 Bausch Health Recent Development

11.7 Takeda Pharmaceutical

11.7.1 Takeda Pharmaceutical Company Details

11.7.2 Takeda Pharmaceutical Business Overview

11.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Introduction

11.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.7.5 Takeda Pharmaceutical Recent Development

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Introduction

11.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.8.5 Novartis Recent Development

11.9 Biogen

11.9.1 Biogen Company Details

11.9.2 Biogen Business Overview

11.9.3 Biogen Inflammatory Bowel Disease (IBD) Treatment Introduction

11.9.4 Biogen Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

11.9.5 Biogen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

Novartis

Biogen

List of Tables

Table 1. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of TNF Inhibitors

Table 3. Key Players of Aminosalicyclates

Table 4. Key Players of Immunomodulators

Table 5. Key Players of Corticosteroids

Table 6. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Region (2020-2025)

Table 10. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Region (2026-2031)

Table 12. Inflammatory Bowel Disease (IBD) Treatment Market Trends

Table 13. Inflammatory Bowel Disease (IBD) Treatment Market Drivers

Table 14. Inflammatory Bowel Disease (IBD) Treatment Market Challenges

Table 15. Inflammatory Bowel Disease (IBD) Treatment Market Restraints

Table 16. Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Players (2020-2025)

Table 18. Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2024)

Table 19. Ranking of Global Top Inflammatory Bowel Disease (IBD) Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Inflammatory Bowel Disease (IBD) Treatment, Headquarters and Area Served

Table 22. Global Key Players of Inflammatory Bowel Disease (IBD) Treatment, Product and Application

Table 23. Global Key Players of Inflammatory Bowel Disease (IBD) Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. AbbVie Company Details

Table 49. AbbVie Business Overview

Table 50. AbbVie Inflammatory Bowel Disease (IBD) Treatment Product

Table 51. AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Pfizer Company Details

Table 54. Pfizer Business Overview

Table 55. Pfizer Inflammatory Bowel Disease (IBD) Treatment Product

Table 56. Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 57. Pfizer Recent Development

Table 58. Takeda Company Details

Table 59. Takeda Business Overview

Table 60. Takeda Inflammatory Bowel Disease (IBD) Treatment Product

Table 61. Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 62. Takeda Recent Development

Table 63. Janssen Biotech Company Details

Table 64. Janssen Biotech Business Overview

Table 65. Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Product

Table 66. Janssen Biotech Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 67. Janssen Biotech Recent Development

Table 68. Allergan Company Details

Table 69. Allergan Business Overview

Table 70. Allergan Inflammatory Bowel Disease (IBD) Treatment Product

Table 71. Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 72. Allergan Recent Development

Table 73. Bausch Health Company Details

Table 74. Bausch Health Business Overview

Table 75. Bausch Health Inflammatory Bowel Disease (IBD) Treatment Product

Table 76. Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 77. Bausch Health Recent Development

Table 78. Takeda Pharmaceutical Company Details

Table 79. Takeda Pharmaceutical Business Overview

Table 80. Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Product

Table 81. Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 82. Takeda Pharmaceutical Recent Development

Table 83. Novartis Company Details

Table 84. Novartis Business Overview

Table 85. Novartis Inflammatory Bowel Disease (IBD) Treatment Product

Table 86. Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 87. Novartis Recent Development

Table 88. Biogen Company Details

Table 89. Biogen Business Overview

Table 90. Biogen Inflammatory Bowel Disease (IBD) Treatment Product

Table 91. Biogen Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025) & (US$ Million)

Table 92. Biogen Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Inflammatory Bowel Disease (IBD) Treatment Picture

Figure 2. Global Inflammatory Bowel Disease (IBD) Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Type: 2024 VS 2031

Figure 4. TNF Inhibitors Features

Figure 5. Aminosalicyclates Features

Figure 6. Immunomodulators Features

Figure 7. Corticosteroids Features

Figure 8. Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacy Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Online Pharmacy Case Studies

Figure 13. Inflammatory Bowel Disease (IBD) Treatment Report Years Considered

Figure 14. Global Inflammatory Bowel Disease (IBD) Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Inflammatory Bowel Disease (IBD) Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Region: 2024 VS 2031

Figure 17. Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Players in 2024

Figure 18. Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inflammatory Bowel Disease (IBD) Treatment as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2024

Figure 20. North America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2020-2031)

Figure 22. United States Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2020-2031)

Figure 26. Germany Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Inflammatory Bowel Disease (IBD) Treatment Market Share by Region (2020-2031)

Figure 34. China Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2020-2031)

Figure 42. Mexico Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Market Share by Country (2020-2031)

Figure 46. Turkey Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Inflammatory Bowel Disease (IBD) Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 51. Takeda Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 52. Janssen Biotech Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 53. Allergan Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 54. Bausch Health Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 55. Takeda Pharmaceutical Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 57. Biogen Revenue Growth Rate in Inflammatory Bowel Disease (IBD) Treatment Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Coronary Imaging Catheter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32P14840

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Digital Platform for Chronic Kidney Disease (CKD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20V18395

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Continuous Glucose Monitoring Sensor Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32G20014

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9U20281

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions